2012-10-27
AUTHORSJakub Svoboda , Stephen J. Schuster
ABSTRACTPatients with Burkitt lymphoma present a unique challenge to clinicians because of the highly aggressive nature of this neoplasm. Three variants of Burkitt lymphoma are recognized: endemic, sporadic, and immunodeficiency-related [1]. While the epidemiology and some clinical characteristics differ among subtypes, the unifying features are rapid tumor cell growth and a propensity to involve extranodal sites. This chapter will focus on the clinical consequences of these biologic features, which frequently present as oncologic emergencies. These aspects of Burkitt lymphoma need to be readily recognized by physicians caring for these patients since delays in providing optimal therapy can result in poor outcome and early mortality. More... »
PAGES67-80
Burkitt’s Lymphoma
ISBN
978-1-4614-4312-4
978-1-4614-4313-1
http://scigraph.springernature.com/pub.10.1007/978-1-4614-4313-1_4
DOIhttp://dx.doi.org/10.1007/978-1-4614-4313-1_4
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1052389174
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd., 19104, Philadelphia, PA, USA",
"id": "http://www.grid.ac/institutes/grid.412701.1",
"name": [
"Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd., 19104, Philadelphia, PA, USA"
],
"type": "Organization"
},
"familyName": "Svoboda",
"givenName": "Jakub",
"id": "sg:person.0722677225.98",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722677225.98"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd., 19104, Philadelphia, PA, USA",
"id": "http://www.grid.ac/institutes/grid.412701.1",
"name": [
"Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd., 19104, Philadelphia, PA, USA"
],
"type": "Organization"
},
"familyName": "Schuster",
"givenName": "Stephen J.",
"id": "sg:person.011060364477.44",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011060364477.44"
],
"type": "Person"
}
],
"datePublished": "2012-10-27",
"datePublishedReg": "2012-10-27",
"description": "Patients with Burkitt lymphoma present a unique challenge to clinicians because of the highly aggressive nature of this neoplasm. Three variants of Burkitt lymphoma are recognized: endemic, sporadic, and immunodeficiency-related [1]. While the epidemiology and some clinical characteristics differ among subtypes, the unifying features are rapid tumor cell growth and a propensity to involve extranodal sites. This chapter will focus on the clinical consequences of these biologic features, which frequently present as oncologic emergencies. These aspects of Burkitt lymphoma need to be readily recognized by physicians caring for these patients since delays in providing optimal therapy can result in poor outcome and early mortality.",
"editor": [
{
"familyName": "Robertson",
"givenName": "Erle S.",
"type": "Person"
}
],
"genre": "chapter",
"id": "sg:pub.10.1007/978-1-4614-4313-1_4",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": {
"isbn": [
"978-1-4614-4312-4",
"978-1-4614-4313-1"
],
"name": "Burkitt\u2019s Lymphoma",
"type": "Book"
},
"keywords": [
"Burkitt's lymphoma",
"tumor cell growth",
"oncologic emergency",
"clinical characteristics",
"extranodal sites",
"lymphoma presents",
"optimal therapy",
"poor outcome",
"early mortality",
"rapid tumor cell growth",
"biologic features",
"clinical consequences",
"aggressive nature",
"clinical implications",
"patients",
"lymphoma",
"cell growth",
"neoplasms",
"unique challenges",
"therapy",
"mortality",
"clinicians",
"epidemiology",
"subtypes",
"physicians",
"outcomes",
"unifying feature",
"emergency",
"variants",
"features",
"propensity",
"need",
"consequences",
"sites",
"delay",
"present",
"implications",
"challenges",
"growth",
"characteristics",
"aspects",
"chapter",
"nature"
],
"name": "Clinical Implications of Burkitt Lymphoma",
"pagination": "67-80",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1052389174"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/978-1-4614-4313-1_4"
]
}
],
"publisher": {
"name": "Springer Nature",
"type": "Organisation"
},
"sameAs": [
"https://doi.org/10.1007/978-1-4614-4313-1_4",
"https://app.dimensions.ai/details/publication/pub.1052389174"
],
"sdDataset": "chapters",
"sdDatePublished": "2022-05-20T07:42",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/chapter/chapter_167.jsonl",
"type": "Chapter",
"url": "https://doi.org/10.1007/978-1-4614-4313-1_4"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-4313-1_4'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-4313-1_4'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-4313-1_4'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-4313-1_4'
This table displays all metadata directly associated to this object as RDF triples.
110 TRIPLES
23 PREDICATES
67 URIs
60 LITERALS
7 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/978-1-4614-4313-1_4 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1112 |
3 | ″ | schema:author | N59bd32efcaa7472baaa34f63c3b1b9ba |
4 | ″ | schema:datePublished | 2012-10-27 |
5 | ″ | schema:datePublishedReg | 2012-10-27 |
6 | ″ | schema:description | Patients with Burkitt lymphoma present a unique challenge to clinicians because of the highly aggressive nature of this neoplasm. Three variants of Burkitt lymphoma are recognized: endemic, sporadic, and immunodeficiency-related [1]. While the epidemiology and some clinical characteristics differ among subtypes, the unifying features are rapid tumor cell growth and a propensity to involve extranodal sites. This chapter will focus on the clinical consequences of these biologic features, which frequently present as oncologic emergencies. These aspects of Burkitt lymphoma need to be readily recognized by physicians caring for these patients since delays in providing optimal therapy can result in poor outcome and early mortality. |
7 | ″ | schema:editor | Ne7b96f0fb41c4eac8deb17af058330da |
8 | ″ | schema:genre | chapter |
9 | ″ | schema:inLanguage | en |
10 | ″ | schema:isAccessibleForFree | false |
11 | ″ | schema:isPartOf | Nc9c2a5ca3df7416cbf12fc063b561cd7 |
12 | ″ | schema:keywords | Burkitt's lymphoma |
13 | ″ | ″ | aggressive nature |
14 | ″ | ″ | aspects |
15 | ″ | ″ | biologic features |
16 | ″ | ″ | cell growth |
17 | ″ | ″ | challenges |
18 | ″ | ″ | chapter |
19 | ″ | ″ | characteristics |
20 | ″ | ″ | clinical characteristics |
21 | ″ | ″ | clinical consequences |
22 | ″ | ″ | clinical implications |
23 | ″ | ″ | clinicians |
24 | ″ | ″ | consequences |
25 | ″ | ″ | delay |
26 | ″ | ″ | early mortality |
27 | ″ | ″ | emergency |
28 | ″ | ″ | epidemiology |
29 | ″ | ″ | extranodal sites |
30 | ″ | ″ | features |
31 | ″ | ″ | growth |
32 | ″ | ″ | implications |
33 | ″ | ″ | lymphoma |
34 | ″ | ″ | lymphoma presents |
35 | ″ | ″ | mortality |
36 | ″ | ″ | nature |
37 | ″ | ″ | need |
38 | ″ | ″ | neoplasms |
39 | ″ | ″ | oncologic emergency |
40 | ″ | ″ | optimal therapy |
41 | ″ | ″ | outcomes |
42 | ″ | ″ | patients |
43 | ″ | ″ | physicians |
44 | ″ | ″ | poor outcome |
45 | ″ | ″ | present |
46 | ″ | ″ | propensity |
47 | ″ | ″ | rapid tumor cell growth |
48 | ″ | ″ | sites |
49 | ″ | ″ | subtypes |
50 | ″ | ″ | therapy |
51 | ″ | ″ | tumor cell growth |
52 | ″ | ″ | unifying feature |
53 | ″ | ″ | unique challenges |
54 | ″ | ″ | variants |
55 | ″ | schema:name | Clinical Implications of Burkitt Lymphoma |
56 | ″ | schema:pagination | 67-80 |
57 | ″ | schema:productId | N81a4618e78684bb2b29f0ef9bb46b7b3 |
58 | ″ | ″ | Nbbdf529f007a4f199700a79fb55adfe9 |
59 | ″ | schema:publisher | Nb0b1983809a94edd8c112242d1900b47 |
60 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1052389174 |
61 | ″ | ″ | https://doi.org/10.1007/978-1-4614-4313-1_4 |
62 | ″ | schema:sdDatePublished | 2022-05-20T07:42 |
63 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
64 | ″ | schema:sdPublisher | N73b4866db4fe4c21a69b30c86e9057cb |
65 | ″ | schema:url | https://doi.org/10.1007/978-1-4614-4313-1_4 |
66 | ″ | sgo:license | sg:explorer/license/ |
67 | ″ | sgo:sdDataset | chapters |
68 | ″ | rdf:type | schema:Chapter |
69 | N59bd32efcaa7472baaa34f63c3b1b9ba | rdf:first | sg:person.0722677225.98 |
70 | ″ | rdf:rest | Ndadc25ee4a8a41dfa8fcf3108d29162d |
71 | N73b4866db4fe4c21a69b30c86e9057cb | schema:name | Springer Nature - SN SciGraph project |
72 | ″ | rdf:type | schema:Organization |
73 | N81a4618e78684bb2b29f0ef9bb46b7b3 | schema:name | doi |
74 | ″ | schema:value | 10.1007/978-1-4614-4313-1_4 |
75 | ″ | rdf:type | schema:PropertyValue |
76 | Nb0b1983809a94edd8c112242d1900b47 | schema:name | Springer Nature |
77 | ″ | rdf:type | schema:Organisation |
78 | Nbbdf529f007a4f199700a79fb55adfe9 | schema:name | dimensions_id |
79 | ″ | schema:value | pub.1052389174 |
80 | ″ | rdf:type | schema:PropertyValue |
81 | Nc9c2a5ca3df7416cbf12fc063b561cd7 | schema:isbn | 978-1-4614-4312-4 |
82 | ″ | ″ | 978-1-4614-4313-1 |
83 | ″ | schema:name | Burkitt’s Lymphoma |
84 | ″ | rdf:type | schema:Book |
85 | Ndadc25ee4a8a41dfa8fcf3108d29162d | rdf:first | sg:person.011060364477.44 |
86 | ″ | rdf:rest | rdf:nil |
87 | Ne3449218643b431fb2297fc0cc97f852 | schema:familyName | Robertson |
88 | ″ | schema:givenName | Erle S. |
89 | ″ | rdf:type | schema:Person |
90 | Ne7b96f0fb41c4eac8deb17af058330da | rdf:first | Ne3449218643b431fb2297fc0cc97f852 |
91 | ″ | rdf:rest | rdf:nil |
92 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
93 | ″ | schema:name | Medical and Health Sciences |
94 | ″ | rdf:type | schema:DefinedTerm |
95 | anzsrc-for:1112 | schema:inDefinedTermSet | anzsrc-for: |
96 | ″ | schema:name | Oncology and Carcinogenesis |
97 | ″ | rdf:type | schema:DefinedTerm |
98 | sg:person.011060364477.44 | schema:affiliation | grid-institutes:grid.412701.1 |
99 | ″ | schema:familyName | Schuster |
100 | ″ | schema:givenName | Stephen J. |
101 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011060364477.44 |
102 | ″ | rdf:type | schema:Person |
103 | sg:person.0722677225.98 | schema:affiliation | grid-institutes:grid.412701.1 |
104 | ″ | schema:familyName | Svoboda |
105 | ″ | schema:givenName | Jakub |
106 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722677225.98 |
107 | ″ | rdf:type | schema:Person |
108 | grid-institutes:grid.412701.1 | schema:alternateName | Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd., 19104, Philadelphia, PA, USA |
109 | ″ | schema:name | Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd., 19104, Philadelphia, PA, USA |
110 | ″ | rdf:type | schema:Organization |